Teaching HospitalCached Profile
University of Miami Hospital
Address: 1400 NW 12th Ave, Miami, FL 33136
CCN Number: 100079
LIFETIME INDUSTRY FOOTPRINT
$622,562
General Payments Aggregated (2021–2024)
Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.
Top Funding Sources (Cumulative)
Corporate pharmaceutical and medical device manufacturers contributing to overall totals.
1. GENENTECH$285,000 (45.8%)
2. REGENERON PHARMACEUTICALS$75,000 (12.0%)
3. APELLIS PHARMACEUTICALS$51,750 (8.3%)
Active & Completed Clinical Trials
Medical trials listing this teaching hospital as sponsor or collaborator.
A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled Study of Ivosidenib in Participants ≥18 Years of Age With Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen
RECRUITINGPhase PHASE3NCT06127407
A Phase 2 Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Tolerability and Efficacy of Volixibat Potassium, an Apical Sodium-Dependent Bile Acid Transporter Inhibitor (ASBTi) in Adults With Nonalcoholic Steatohepatitis (NASH)
TERMINATEDPhase PHASE2NCT02787304
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Safety Study of Pimavanserin Therapy in Adult and Elderly Subjects Experiencing Neuropsychiatric Symptoms Related to Neurodegenerative Disease
COMPLETEDPhase PHASE3NCT03575052
Teaching Hospital General Payouts Log
Federal registry records of promotional speaking, consulting, meals, and offsets.
Year:
2024
2024
2023
2022
2021
Querying Open Payments Database
Fetching live CMS.gov records for 100079...